ResMed slips after Stifel cuts PT
** Shares of medical device maker ResMed RMD.N down 4.3% at $221.44 ** Stifel cuts PT to $240 from $250, reiterates "hold" rating ** Eleven brokerages rate company "buy" or higher, while six "hold" and one "strong sell"; median PT at $278.66 - LSEG data ** Including session's move, stock down 3.1% YTD (Reporting by Jaiveer Singh Shekhawat in Bengaluru) ((JaiveerSingh.Shekhawat@thomsonreuters.com;))
Recent news on ResMed
See all newsCiti lifts ResMed's ASX-listed stock's target price after FX, valuation updates
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
S&P 500 top and bottom performing stocks at about 12:00 p.m. EDT
Brief: Resmed - Enters Accelerated Share Repurchase Agreement To Repurchase $450 Million Of Common Stock - SEC Filing
S&P 500 top and bottom performing stocks at about 03:30 p.m. EDT